I received my second PhD in Computer Science (with a focus on distributed systems and software engineering) from Virginia Tech USA in 2020, and the first PhD (with a focus on wireless networking and mobile computing) from Beijing University of Posts and Telecommunications China in 2015. I received the Best Paper Award from IEEE International Conference on Edge Computing in 2019. My ongoing research projects include measuring the data quality of web services and using federated learning to improve indoor localization accuracy.
Dr. Gen Li is an Assistant Professor in the Department of Biostatistics. He is devoted to developing new statistical methods for analyzing complex biomedical data, including multi-way tensor array data, multi-view data, and compositional data. His methodological research interests include dimension reduction, predictive modeling, association analysis, and functional data analysis. He also has research interests in scientific domains including microbiome and genomics.
The primary tools currently in use are variations of linear models (regression, MLM, SEM, and so on) as we pursue the initial aims of the NICHD funded work. We are expanding into new areas that require new tools. Our adolescent sample is diverse, selected through quota sampling of high schools close enough to UM to afford the use of neuroimaging tools, but it is not population representative. To overcome this, we have begun work to calibrate our sample with the nationally representative Monitoring the Future study, implementing pseudo-weighting and multilevel regression and post-stratification. To enable much more powerful analyses, we are aiming toward the harmonization of multiple, high quality longitudinal databases from adolescence through early adulthood. This would benefit traditional analyses by allowing cross-validation with high power, but also provide opportunities for newer data science tools such as computational modeling and machine learning approaches.
I have been involved in the building of data infrastructure in the study of elections, political systems, violence, geospatial units, demographics, and topography. This infrastructure will eventually lead to the integration of data across many domains in the social, health, population, and behavioral sciences. My core research interests are in elections and political organizations.
My research primarily focuses on the following main themes: 1) development of methods for risk prediction and analyzing treatment effect heterogeneity, 2) Bayesian nonparametrics and Bayesian machine learning methods with a particular emphasis on the use of these methods in the context of survival analysis, 3) statistical methods for analyzing heterogeneity in risk-benefit profiles and for supporting individualized treatment decisions, and 4) development of empirical Bayes and shrinkage methods for high-dimensional statistical applications. I am also broadly interested in collaborative work in biomedical research with a focus on the application of statistics in cancer research.
J. Trent Alexander is the Associate Director and a Research Professor at ICPSR in the Institute for Social Research at the University of Michigan. Alexander is a historical demographer and builds social science data infrastructure. He is currently leading the Decennial Census Digitization and Linkage Project (joint with Raj Chetty and Katie Genadek) and ResearchDataGov (joint with Lynette Hoelter). Prior to coming to ICPSR in 2017, Alexander initiated the Census Longitudinal Infrastructure Project at the Census Bureau and managed the Integrated Public Use Microdata Series (IPUMS) at the University of Minnesota.
We use a variety of quantitative imaging methods, ranging from single cells to clinical studies, to investigate cancer signaling and response to therapy over space and time. We develop image analysis methods to extract data from thousands of single cells over time and voxel-wise measurements of imaging parameters. We also use bulk and single-cell RNA sequencing to investigate heterogeneity among cancer cells and changes induced by intercellular interactions. A current goal of our ongoing work is to merge RNA sequencing and imaging data to understand cell decision making in cancer. We collaborate with investigators using machine learning and computational modeling approaches to inform cell signaling and resultant behaviors in tumor growth and metastasis.
My research interest lies in applying data science for actionable transformation of human health from the bench to bedside. Current research focus areas include cutting edge single-cell sequencing informatics and genomics; precision medicine through integration of multi-omics data types; novel modeling and computational methods for biomarker research; public health genomics. I apply my biomedical informatics and analytical expertise to study diseases such as cancers, as well the impact of pregnancy/early life complications on later life diseases.
My methodological research focus on developing statistical methods for routinely collected healthcare databases such as electronic health records (EHR) and claims data. I aim to tackle the unique challenges that arise from the secondary use of real-world data for research purposes. Specifically, I develop novel causal inference methods and semiparametric efficiency theory that harness the full potential of EHR data to address comparative effectiveness and safety questions. I develop scalable and automated pipelines for curation and harmonization of EHR data across healthcare systems and coding systems.
Our laboratory focuses on (1) the biology of cancer metastasis, especially bone metastasis, including the role of the host microenvironment; and (2) mechanisms of chemoresistance. We explore for genes that regulate metastasis and the interaction between the host microenvironment and cancer cells. We are performing single cell multiomics and spatial analysis to enable us to identify rare cell populations and promote precision medicine. Our research methodology uses a combination of molecular, cellular, and animal studies. The majority of our work is highly translational to provide clinical relevance to our work. In terms of data science, we collaborate on applications of both established and novel methodologies to analyze high dimensional; deconvolution of high dimensional data into a cellular and tissue context; spatial mapping of multiomic data; and heterogenous data integration.